Bioprotocol (bio) tokens surged 27% today, continuing their monthly rallies of an astounding 300%.
The launch of the upcoming Aubrai AI-powered science agent has created great excitement among Desci investors.
The whale accumulation and Arthur Hayes’ $1 million investment have boosted confidence in Bio’s future.
Bio Protocol (Bio) Token surprised the crypto market with a sharp rise. It jumped over 27% in the last 24 hours alone, and last month it won nearly 300% of the tokens. This huge growth is linked not only by chance, but also with new product launches, big partnerships and strong support from both retail and institutional investors.
Is this the important reason behind price increases?
Aubrai launches excitement
One of the biggest reasons behind Bio Token Rally is the upcoming launch of Aubrai, Bio Protocol’s first AI-driven distributed science agent, built in partnership with Vitadao.
This development has created strong excitement among the distributed science science (DESCI) community and investors looking at long-term potential in the project.
This Monday marks the beginning of @aubrai_
The first ignition sale is here.
This is what you need to know
>How to participate
Sales run 24 hours on Bio Launchpad: https://t.co/ii8xyzdnwy
For sale, I pledge my BIOXP and committed my $BIO…pic.twitter.com/ek5xkpu6wo
– Bioprotocol (@bioprotocol) August 22, 2025
List and Staking Fuel Rally
Another factor in the surge is Bio’s Coinbase list for July 2025. This makes it easier for more people to buy and trade tokens. At the same time, the launch of Bio’s staking programme has locked over 125 million tokens, making a 400% jump from the previous level.
This supply shock caused prices to rise, with tokens rising above $0.26 and market capitalization approaching $400 million, resulting in daily volumes reaching $1 billion.
Whale accumulation and big investment
Surges are also driven by whales accumulation and well-known investments. Bitmex co-founder Arthur Hayes reportedly poured $1 million into the bio to fuel the bullish fire.
Meanwhile, Binance Labs has already supported bioprotocols in 2024, further solidifying its institutional support. However, the $80,000 funding for a Phase 2 clinical trial of brain health added a basic boost.
As exchange balances decrease, supply shrinks
Bio exchange balances fell sharply as more holders moved their tokens to their own stance. This trend shows strong belief among investors and reduces the available supply. This is a classic setup for bullish price action.
Technical analysis: Overbuying but strong
On the charts, Bio recently completed a double bottom breakout of over $0.1023, extending the price to $0.26, heading towards $0.1650. However, analysts warn of possible pullbacks as RSI is at 75 and other oscillators in other acquired territory.
If that happens, the price could retest the support level of $0.1023. Still, as long as this important support applies, the overall trend remains bullish.
